$OMER News

Omeros: Yartemlea Faces Headwinds While We Wait On Pipeline Developments

Why Is OMER Stock Falling Today?

Omeros Corporation Announces Update on European Marketing Authorization Application for Narsoplimab in TA-TMA

HC Wainwright & Co. Maintains Buy on Omeros, Lowers Price Target to $33

FDA Approved, Europe Unconvinced: Omeros' Stem Cell Transplant Treatment Hits Regulatory Divide

Omeros Gets EMA CHMP Negative Opinion On Narsoplimab In TA‑TMA; Co. To Request Re‑Examination And Seek Ad Hoc Expert Group Review

Omeros Announces Webcast Details for Annual Meeting of Shareholders

HC Wainwright & Co. Reiterates Buy on Omeros, Maintains $40 Price Target

Bears are Losing Control Over Omeros (OMER), Here's Why It's a 'Buy' Now

Omeros (OMER) Q1 2026 Earnings Transcript

Omeros Corporation Q1 2026 Earnings Call Summary

HC Wainwright & Co. Reiterates Buy on Omeros, Maintains $40 Price Target

Omeros Corp (OMER) Q1 2026 Earnings Call Highlights: Strong YARTEMLEA Launch and Strategic ...

Omeros Corporation (OMER) Q1 2026 Earnings Call Transcript

Omeros Corp (NASDAQ:OMER) Swings to Profit on YARTEMLEA Launch, Topping EPS Forecasts

Omeros Corporation Reports First Quarter 2026 Financial Results

Omeros Q1 Adj. EPS $(0.24) Beats $(0.32) Estimate, Sales $9.893M Miss $10.125M Estimate

Omeros Corporation to Announce First Quarter Financial Results on May 13, 2026

Here's Why Omeros (OMER) is a Great Momentum Stock to Buy

Wall Street Analysts Believe Omeros (OMER) Could Rally 222.76%: Here's is How to Trade